Bifurcation PCI With a Hybrid Strategy With Drug Eluting Balloons Versus a Stepwise Provisional Two-stent Strategy

NARecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

March 21, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2030

Conditions
Coronary Artery DiseaseCoronary Bifurcation Lesion
Interventions
OTHER

Hybrid DEB approach with drug-eluting balloon

If a patient is randomized to the hybrid DEB approach, lesion preparation of the SB with non-compliant balloon (NC) is mandatory before DEB application. The application of DEB can be performed if acceptable result of the lesion preparation is obtained (at least TIMI III flow and no flow limiting dissection). The drug- eluting balloon used in this study is the CE- marked Magic Touch Sirolimus Coated Balloon Catheter (Concept Medical, Gujarat, India). The size of the DEB is measured on a ratio 1:1 on reference diameter of the SB. The DEB balloon is inflated for 60 seconds, or two times more than 30 seconds if long duration inflations are not possible. Finally low pressure kissing inflation with the same DEB in place, and Proximal Optimization Therapy (POT) are performed. In case of SB occlusion, or flow limiting dissections in non-Left Main (LM) bifurcations and \< TIMI 3 flow or 70-99% residual stenosis in LM bifurcations, cross- over to two-stent technique is performed.

OTHER

Two-stent strategy

When randomized to the conventional two-stent strategy, TAP/T or Culotte stenting is performed. First lesion preparation of the SB is mandatory. The drug-eluting stent (Supraflex stent) can be placed in the SB if acceptable result of the lesion preparation is obtained and is measured on a 1:1 ratio on reference diameter of the SB. Finally, kissing inflation and POT are mandatory.

Trial Locations (1)

5623 EJ

RECRUITING

Catharina Hospital, Eindhoven

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Catharina Ziekenhuis Eindhoven

OTHER

collaborator

Albert Schweitzer Hospital

OTHER

collaborator

Onze Lieve Vrouwe Gasthuis

OTHER

collaborator

Maasstad Hospital

OTHER

collaborator

The Elisabeth-TweeSteden Hospital

OTHER

collaborator

St. Antonius Hospital

OTHER

collaborator

Frisius Medisch Centrum

OTHER

collaborator

Meander Medical Center

OTHER

collaborator

VieCuri Medical Centre

OTHER

collaborator

Haga Hospital

OTHER

collaborator

Rijnstate Hospital

OTHER

collaborator

Jeroen Bosch Ziekenhuis

OTHER

lead

Cathreine BV

OTHER

NCT05731687 - Bifurcation PCI With a Hybrid Strategy With Drug Eluting Balloons Versus a Stepwise Provisional Two-stent Strategy | Biotech Hunter | Biotech Hunter